HB1970, titled the Providing Veterans Essential Medications Act, would amend federal veterans law to address the cost of certain high-priced prescription drugs provided to veterans living in State homes and receiving nursing home care under contract or agreement with the Department of Veterans Affairs. The bill directs the Secretary of Veterans Affairs, at the election of a covered State home, either to reimburse the home for a “costly medication” or to furnish the medication directly to the home.
The bill defines a costly medication as a drug or medicine whose average wholesale price for a one-month supply, plus a 3 percent transaction fee, exceeds 8.5 percent of the VA payment made to the State home for that veteran’s care during that month. In practical terms, the measure is designed to shift or reduce the financial burden on State veterans homes when they must provide unusually expensive medications to residents.
Impact
If enacted, the bill would amend section 1745(a)(3) of title 38, United States Code, creating a new reimbursement or direct-supply obligation for the VA with respect to certain medications provided in State veterans homes. The change would affect State homes that furnish nursing home care to veterans under VA contracts or agreements, and it could reduce out-of-pocket costs or unreimbursed expenses for those facilities when they dispense high-cost drugs. It would also expand the VA’s administrative and fiscal responsibilities by requiring a mechanism to identify qualifying medications and either reimburse homes or provide the drugs directly.
Sentiment
The available context suggests the bill is generally favorable and noncontroversial. It was introduced by bipartisan sponsors and referred to the House Committee on Veterans’ Affairs, then to the Subcommittee on Health, with no recorded votes or committee debate provided. The title and structure indicate a targeted veterans-benefits measure intended to solve a specific funding problem for State homes rather than a broader policy overhaul.
Contention
No explicit opposition or contested issues appear in the provided materials. The main policy question implied by the text is whether the VA should absorb the cost of expensive medications through reimbursement or direct furnishing, and how the threshold for a “costly medication” should be calculated. Potential stakeholders include the VA, State veterans homes, and veterans receiving nursing home care, but the record provided does not show any stated objections from any of those groups.
In State Veterans' Commission and Deputy Adjutant General for Veterans' Affairs, further providing for Veterans' Trust Fund; in veterans' organizations, further providing for grants to veterans' service officer programs and providing for veterans' claims assistance standards; and imposing penalties.